Emerging Dematiaceous and Hyaline Fungi Causing Keratitis in a Tertiary Care Centre From North India

被引:23
作者
Ghosh, Anup [1 ]
Kaur, Harsimran [1 ]
Gupta, Amit [2 ]
Singh, Shreya [1 ]
Rudramurthy, Shivaprakash Mandya [1 ]
Gupta, Sunita [1 ]
Chakrabarti, Arunaloke [1 ]
机构
[1] Postgrad Inst Med Educ & Res PGIMER, Dept Med Microbiol, 2nd Floor,Res Block A,Sect 12, Chandigarh 160012, India
[2] PGIMER, Adv Eye Ctr, Dept Ophthalmol, Chandigarh, India
关键词
fungal keratitis; rare fungi; dematiaceous; MYCOTIC KERATITIS; EPICOCCUM-NIGRUM; CYLINDROCARPON; IDENTIFICATION; ONYCHOMYCOSIS; KERATOMYCOSIS; INFECTION; DIAGNOSIS; PATIENT; SERIES;
D O I
10.1097/ICO.0000000000002295
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To report rare dematiaceous and hyaline fungal pathogens causing fungal keratitis (FK) at our center and review the published literature in this field. Methods: In a retrospective review of FK cases from 2005 to 2011, a total of 14 rare pathogens causing isolated cases of FK of a total of 393 isolates were revived from our collection and reconfirmed by using molecular techniques. The in vitro antifungal susceptibility testing (AFST) was performed against a 6-antifungal drug panel by the CLSI microbroth-dilution method. We reviewed the literature on keratitis due to these rare fungi. Results: Two novel fungi,Alternaria tenuissimaandEpicoccum nigrum, were reported in addition to 6 dematiaceous (black pigmented) fungi (Acrophialophora fusispora,Chaetomium globosum,Cladophialophora carionii,Nigrospora sphaerica,Papulaspora equi, andScytalidium lignicola), 5 hyaline (colorless) fungi (Aspergillus tamarii,Fusarium chlamydosporum,Fusarium incarnatum,Fusarium lichenicola, andFusarium sacchari), and one yeast (Trichosporon asahii). Amphotericin B had good in vitro activity (minimum inhibitory concentration [MIC] <= 1 mu g/mL) against most dematiaceous fungi, but not hyaline fungi (MIC >= 1 mu g/mL). Natamycin showed variable MIC, itraconazole and voriconazole had good in vitro activity, except inFusariumspecies.Alternaria tenuissimaandA. fusisporahad a very high MIC (>= 16 mu g/mL) against echinocandins. Literature search revealed 27 FK cases due toF. lichenicola(n = 6),P. equi(n = 5),F. sacchari(n = 4),A. fusispora(n = 3),S. lignicola(n = 2), and others (n = 7), and more than 50% of these were reported from India. Conclusions: Plant fungal pathogens with variable antifungal susceptibility are an emerging cause of human keratitis with predominance of dematiaceous fungi. Identification and antifungal susceptibility testing are important for epidemiology and to optimize therapy and improve the patient outcome.
引用
收藏
页码:868 / 876
页数:9
相关论文
共 41 条
[31]   Alternaria infections:: laboratory diagnosis and relevant clinical features [J].
Pastor, F. J. ;
Guarro, J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (08) :734-746
[32]  
Riddell J IV, 2010, INFECT DIS REP, V2, P47, DOI [10.4081/idr.2010.1939, 10.4081/idr.2010.e14]
[33]   Cutaneous infection with Alternaria tenuissima in an immunocompromised patient [J].
Robertshaw, H ;
Higgins, E .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (05) :1047-1049
[34]   Series of Five Cases of Papulaspora equi Keratomycosis [J].
Selvin, Satheesh S. T. ;
Korah, Sanita M. G. ;
Michael, Joy S. ;
Raj, Promila M. ;
Jacob, Pushpa .
CORNEA, 2014, 33 (06) :640-643
[35]   Perinephric abscess caused by fusarium chlamydosporum in an immunocompetent child: Case report and identification of the morphologically atypical fungal strain [J].
Shailpreet, Sidhu ;
Chander, Jagdish ;
Singh, Kiran .
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2013, 56 (03) :312-314
[36]  
SHUKLA PK, 1983, SABOURAUDIA, V21, P137
[37]  
Suchitra MS, 2012, J CLIN DIAGN RES, V6, P905
[38]   Intramuscular Epicoccum nigrum infection in an immunocompromised patient: A case report [J].
Suraiya, S. ;
Azira, N. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 :S45-S46
[39]   Mycotic keratitis: epidemiology, diagnosis and management [J].
Thomas, P. A. ;
Kaliamurthy, J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (03) :210-220
[40]  
Tilak R, 2014, J INFECT DEV COUNTR, V4, P171